CN Stock MarketDetailed Quotes

688578 Shanghai Allist Pharmaceuticals Co., Ltd.

Watchlist
  • 89.13
  • +2.38+2.74%
Market Closed Apr 24 15:00 CST
40.11BMarket Cap26.14P/E (TTM)

Shanghai Allist Pharmaceuticals Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
Total operating revenue
47.86%1.1B
76.29%3.56B
87.97%2.53B
110.57%1.58B
168.65%742.84M
155.14%2.02B
160.34%1.35B
149.24%748.67M
148.75%276.51M
49.22%791M
Operating revenue
47.86%1.1B
76.29%3.56B
87.97%2.53B
110.57%1.58B
168.65%742.84M
155.14%2.02B
160.34%1.35B
149.24%748.67M
148.75%276.51M
49.22%791M
Total operating cost
47.77%641.31M
42.98%2.02B
47.41%1.4B
57.95%875.21M
70.41%433.99M
97.79%1.42B
90.77%952.29M
87.13%554.09M
71.79%254.67M
21.41%715.47M
Operating cost
5.50%35.79M
84.26%143.49M
106.02%106.33M
136.16%68.83M
305.51%33.92M
145.51%77.87M
135.80%51.61M
132.43%29.15M
63.30%8.37M
461.92%31.72M
Operating tax surcharges
47.02%15.48M
82.91%48.66M
109.68%36.75M
138.51%22.55M
216.39%10.53M
421.10%26.6M
733.63%17.53M
605.28%9.45M
481.37%3.33M
82.74%5.11M
Operating expense
44.65%452.82M
53.53%1.41B
53.28%988.2M
67.84%621.72M
94.32%313.04M
113.25%920.51M
115.47%644.68M
117.21%370.42M
113.09%161.1M
60.70%431.66M
Administration expense
59.21%56.34M
25.16%164.59M
30.59%109.2M
26.19%68.74M
54.00%35.39M
42.25%131.51M
15.36%83.62M
27.27%54.47M
13.87%22.98M
-5.50%92.45M
Financial expense
52.78%-10.87M
-12.18%-61.05M
-21.53%-44.35M
-67.83%-37.88M
-396.73%-23.01M
-46.26%-54.43M
-8.06%-36.5M
-12.56%-22.57M
-63.88%-4.63M
-355.77%-37.21M
-Interest expense (Financial expense)
90.31%36.79K
-58.98%65.96K
-34.53%50.23K
-58.04%32.2K
-63.61%19.33K
-50.58%160.79K
-52.38%76.73K
-28.18%76.73K
0.00%53.12K
-46.23%325.32K
-Interest Income (Financial expense)
51.15%-11.32M
-17.91%-59.28M
-62.26%-48.79M
-146.33%-37.75M
-241.96%-23.18M
-146.40%-50.28M
-119.67%-30.07M
-80.43%-15.32M
-69.65%-6.78M
-67.53%-20.41M
Research and development
43.08%91.75M
0.46%314.49M
8.53%207.67M
15.98%131.25M
0.93%64.13M
63.26%313.06M
39.38%191.35M
27.26%113.17M
28.10%63.54M
-13.86%191.75M
Credit Impairment Loss
955.60%232.16K
-122.41%-159.39K
117.43%108.72K
131.58%177.37K
88.79%-27.13K
152.30%711.18K
-663.47%-623.93K
-358.11%-561.74K
-41.72%-242.15K
-171.11%-1.36M
Asset Impairment Loss
----
----
----
----
----
----
----
----
----
128.00%651.12K
Other net revenue
Fair value change income
391.15%11.44M
27.39%28.89M
-18.50%17.7M
-50.24%8.28M
-74.17%2.33M
-29.92%22.67M
-6.79%21.72M
14.52%16.65M
-0.15%9.02M
-32.78%32.36M
Invest income
232.72%4.8M
-21.70%7.76M
-37.60%4.49M
-64.93%2.14M
-37.32%1.44M
-21.68%9.91M
-27.15%7.2M
-5.91%6.1M
-46.73%2.3M
-29.23%12.65M
Asset deal income
--20.9K
----
----
----
----
-48.02%16.78K
--7.24K
---34.82K
---23.21K
--32.27K
Other revenue
165.26%3.52M
199.25%63.74M
1,158.80%47.98M
-61.07%1.48M
-65.09%1.33M
167.86%21.3M
146.20%3.81M
207.70%3.8M
207.83%3.8M
-55.47%7.95M
Operating profit
51.98%477.08M
148.57%1.63B
180.61%1.2B
223.46%713.35M
755.71%313.92M
414.55%657.67M
691.46%427.62M
723.98%220.54M
261.80%36.69M
485.55%127.81M
Add:Non operating Income
----
339.55%266.41
--266.41
--2.25
--1.93
-98.42%60.61
----
----
----
-44.86%3.83K
Less:Non operating expense
6,475.12%1.32M
1,021.76%16.23M
731.06%8.89M
18.78%1.22M
1,571.43%20K
-20.48%1.45M
958.11%1.07M
268,409.63%1.03M
234.02%1.2K
-48.90%1.82M
Total profit
51.57%475.76M
146.64%1.62B
179.23%1.19B
224.42%712.13M
755.68%313.9M
420.82%656.22M
690.90%426.55M
720.15%219.51M
261.79%36.68M
589.48%126M
Less:Income tax cost
731.96%65.27M
1,466.23%188.67M
694.58%128.13M
404.68%55.99M
334.24%7.84M
366.41%12.05M
--16.13M
--11.09M
--1.81M
---4.52M
Net profit
34.13%410.5M
121.97%1.43B
158.99%1.06B
214.82%656.14M
777.51%306.05M
393.54%644.17M
661.00%410.43M
678.69%208.41M
253.83%34.88M
614.22%130.52M
Net profit from continuing operation
34.13%410.5M
121.97%1.43B
158.99%1.06B
214.82%656.14M
777.51%306.05M
393.54%644.17M
661.00%410.43M
678.69%208.41M
253.83%34.88M
614.22%130.52M
Net profit of parent company owners
34.13%410.5M
121.97%1.43B
158.99%1.06B
214.82%656.14M
777.51%306.05M
393.54%644.17M
661.00%410.43M
678.69%208.41M
253.83%34.88M
614.22%130.52M
Earning per share
Basic earning per share
33.82%0.91
122.38%3.18
159.34%2.36
217.39%1.46
750.00%0.68
393.10%1.43
658.33%0.91
666.67%0.46
260.00%0.08
625.00%0.29
Diluted earning per share
33.82%0.91
122.38%3.18
159.34%2.36
217.39%1.46
750.00%0.68
393.10%1.43
658.33%0.91
666.67%0.46
260.00%0.08
625.00%0.29
Other composite income
-555.69%-63.76M
10.86%84.27M
3,286.22%55.17M
908.49%19.94M
2,089.40%13.99M
429.36%76.01M
-62.61%1.63M
-2.11%1.98M
-703.31K
341.34%14.36M
Other composite income of parent company owners
-555.69%-63.76M
10.86%84.27M
3,286.22%55.17M
908.49%19.94M
2,089.40%13.99M
429.36%76.01M
-62.61%1.63M
-2.11%1.98M
---703.31K
341.34%14.36M
Total composite income
8.34%346.74M
110.24%1.51B
171.35%1.12B
221.34%676.08M
836.51%320.04M
397.09%720.19M
606.91%412.06M
630.92%210.39M
250.72%34.17M
572.98%144.88M
Total composite income of parent company owners
8.34%346.74M
110.24%1.51B
171.35%1.12B
221.34%676.08M
836.51%320.04M
397.09%720.19M
606.91%412.06M
630.92%210.39M
250.72%34.17M
572.98%144.88M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022
Total operating revenue 47.86%1.1B76.29%3.56B87.97%2.53B110.57%1.58B168.65%742.84M155.14%2.02B160.34%1.35B149.24%748.67M148.75%276.51M49.22%791M
Operating revenue 47.86%1.1B76.29%3.56B87.97%2.53B110.57%1.58B168.65%742.84M155.14%2.02B160.34%1.35B149.24%748.67M148.75%276.51M49.22%791M
Total operating cost 47.77%641.31M42.98%2.02B47.41%1.4B57.95%875.21M70.41%433.99M97.79%1.42B90.77%952.29M87.13%554.09M71.79%254.67M21.41%715.47M
Operating cost 5.50%35.79M84.26%143.49M106.02%106.33M136.16%68.83M305.51%33.92M145.51%77.87M135.80%51.61M132.43%29.15M63.30%8.37M461.92%31.72M
Operating tax surcharges 47.02%15.48M82.91%48.66M109.68%36.75M138.51%22.55M216.39%10.53M421.10%26.6M733.63%17.53M605.28%9.45M481.37%3.33M82.74%5.11M
Operating expense 44.65%452.82M53.53%1.41B53.28%988.2M67.84%621.72M94.32%313.04M113.25%920.51M115.47%644.68M117.21%370.42M113.09%161.1M60.70%431.66M
Administration expense 59.21%56.34M25.16%164.59M30.59%109.2M26.19%68.74M54.00%35.39M42.25%131.51M15.36%83.62M27.27%54.47M13.87%22.98M-5.50%92.45M
Financial expense 52.78%-10.87M-12.18%-61.05M-21.53%-44.35M-67.83%-37.88M-396.73%-23.01M-46.26%-54.43M-8.06%-36.5M-12.56%-22.57M-63.88%-4.63M-355.77%-37.21M
-Interest expense (Financial expense) 90.31%36.79K-58.98%65.96K-34.53%50.23K-58.04%32.2K-63.61%19.33K-50.58%160.79K-52.38%76.73K-28.18%76.73K0.00%53.12K-46.23%325.32K
-Interest Income (Financial expense) 51.15%-11.32M-17.91%-59.28M-62.26%-48.79M-146.33%-37.75M-241.96%-23.18M-146.40%-50.28M-119.67%-30.07M-80.43%-15.32M-69.65%-6.78M-67.53%-20.41M
Research and development 43.08%91.75M0.46%314.49M8.53%207.67M15.98%131.25M0.93%64.13M63.26%313.06M39.38%191.35M27.26%113.17M28.10%63.54M-13.86%191.75M
Credit Impairment Loss 955.60%232.16K-122.41%-159.39K117.43%108.72K131.58%177.37K88.79%-27.13K152.30%711.18K-663.47%-623.93K-358.11%-561.74K-41.72%-242.15K-171.11%-1.36M
Asset Impairment Loss ------------------------------------128.00%651.12K
Other net revenue
Fair value change income 391.15%11.44M27.39%28.89M-18.50%17.7M-50.24%8.28M-74.17%2.33M-29.92%22.67M-6.79%21.72M14.52%16.65M-0.15%9.02M-32.78%32.36M
Invest income 232.72%4.8M-21.70%7.76M-37.60%4.49M-64.93%2.14M-37.32%1.44M-21.68%9.91M-27.15%7.2M-5.91%6.1M-46.73%2.3M-29.23%12.65M
Asset deal income --20.9K-----------------48.02%16.78K--7.24K---34.82K---23.21K--32.27K
Other revenue 165.26%3.52M199.25%63.74M1,158.80%47.98M-61.07%1.48M-65.09%1.33M167.86%21.3M146.20%3.81M207.70%3.8M207.83%3.8M-55.47%7.95M
Operating profit 51.98%477.08M148.57%1.63B180.61%1.2B223.46%713.35M755.71%313.92M414.55%657.67M691.46%427.62M723.98%220.54M261.80%36.69M485.55%127.81M
Add:Non operating Income ----339.55%266.41--266.41--2.25--1.93-98.42%60.61-------------44.86%3.83K
Less:Non operating expense 6,475.12%1.32M1,021.76%16.23M731.06%8.89M18.78%1.22M1,571.43%20K-20.48%1.45M958.11%1.07M268,409.63%1.03M234.02%1.2K-48.90%1.82M
Total profit 51.57%475.76M146.64%1.62B179.23%1.19B224.42%712.13M755.68%313.9M420.82%656.22M690.90%426.55M720.15%219.51M261.79%36.68M589.48%126M
Less:Income tax cost 731.96%65.27M1,466.23%188.67M694.58%128.13M404.68%55.99M334.24%7.84M366.41%12.05M--16.13M--11.09M--1.81M---4.52M
Net profit 34.13%410.5M121.97%1.43B158.99%1.06B214.82%656.14M777.51%306.05M393.54%644.17M661.00%410.43M678.69%208.41M253.83%34.88M614.22%130.52M
Net profit from continuing operation 34.13%410.5M121.97%1.43B158.99%1.06B214.82%656.14M777.51%306.05M393.54%644.17M661.00%410.43M678.69%208.41M253.83%34.88M614.22%130.52M
Net profit of parent company owners 34.13%410.5M121.97%1.43B158.99%1.06B214.82%656.14M777.51%306.05M393.54%644.17M661.00%410.43M678.69%208.41M253.83%34.88M614.22%130.52M
Earning per share
Basic earning per share 33.82%0.91122.38%3.18159.34%2.36217.39%1.46750.00%0.68393.10%1.43658.33%0.91666.67%0.46260.00%0.08625.00%0.29
Diluted earning per share 33.82%0.91122.38%3.18159.34%2.36217.39%1.46750.00%0.68393.10%1.43658.33%0.91666.67%0.46260.00%0.08625.00%0.29
Other composite income -555.69%-63.76M10.86%84.27M3,286.22%55.17M908.49%19.94M2,089.40%13.99M429.36%76.01M-62.61%1.63M-2.11%1.98M-703.31K341.34%14.36M
Other composite income of parent company owners -555.69%-63.76M10.86%84.27M3,286.22%55.17M908.49%19.94M2,089.40%13.99M429.36%76.01M-62.61%1.63M-2.11%1.98M---703.31K341.34%14.36M
Total composite income 8.34%346.74M110.24%1.51B171.35%1.12B221.34%676.08M836.51%320.04M397.09%720.19M606.91%412.06M630.92%210.39M250.72%34.17M572.98%144.88M
Total composite income of parent company owners 8.34%346.74M110.24%1.51B171.35%1.12B221.34%676.08M836.51%320.04M397.09%720.19M606.91%412.06M630.92%210.39M250.72%34.17M572.98%144.88M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion------Unqualified opinion
Auditor ----------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Giansun Precision Technology Group
001400
+78.53%
Heilongjiang Tianyouwei Electronics
603202
+24.06%
Joy Kie Corporation
300994
+20.03%
4
Kingchem
301509
+20.02%
5
Hunan Er-kang Pharmaceutical
300267
+20.00%
Log In for the Full List
Unlock Now